Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis

NCT00004816 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.

NCT NCT00004816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis
Lead sponsor
National Center for Research Resources (NCRR)
Phase
Phase 1
Overall status
Completed
Start date
July 31, 1995
Completion date
Not reported
Enrollment
25
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis